Amgen
Trade Amgen 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About AMGN
Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K.
AMGN Key Statistics
Stock Snapshot
With a market cap of 182.89B, Amgen(AMGN) trades at $339.64. The stock has a price-to-earnings ratio of 24.79 and currently yields dividends of 3.0%.
On 2026-01-07, Amgen(AMGN) stock moved within a range of $331.00 to $343.05. With shares now at $339.64, the stock is trading +2.6% above its intraday low and -1.0% below the session's peak.
Trading activity shows a volume of 1.6M, compared to an average daily volume of 1.7M.
Over the past 52 weeks, Amgen(AMGN) stock has traded between a high of $346.38 and a low of $259.35.
Over the past 52 weeks, Amgen(AMGN) stock has traded between a high of $346.38 and a low of $259.35.
AMGN News
On Tuesday, Amgen Inc. (NASDAQ:AMGN) acquired Dark Blue Therapeutics, a discovery and development biotech company focused on precision oncology medicines. The...
Amgen Inc (AMGN) announced an update on their ongoing clinical study. Claim 70% Off TipRanks Premium Unlock hedge fund-level data and powerful investing tools f...
In early trading on Wednesday, shares of Amgen topped the list of the day's best performing Dow Jones Industrial Average components, trading up 2.6%. Year to da...
Analyst ratings
48%
of 33 ratingsMore AMGN News
Amgen AMGN announced that it has acquired U.K.-based private biotech company, Dark Blue Therapeutics, for approximately $840 million. The acquisition will stre...
Amgen Inc. ( ) will increase its dividend from last year's comparable payment on the 6th of March to $2.52. The payment will take the dividend yield to 3.1%, wh...
UBS upgraded Amgen (AMGN) to Buy from Neutral with a price target of $380, up from $317, as the analyst assumed coverage of the stock. While the firm notes that...
Shares in drug developer Amgen (AMGN) looked brighter today after it bought Dark Blue Therapeutics, a British cancer-fighting biotech for $840 million. Claim 7...
(RTTNews) - Amgen, Inc. (AMGN) announced Tuesday its acquisition of UK-based privately-held biotechnology company Dark Blue Therapeutics Ltd. in a transaction v...
Amgen (AMGN) announced its acquisition of Dark Blue Therapeutics, a privately held biotechnology company based in the United Kingdom advancing first-in-class, s...
Axsome Therapeutics (AXSM) shares rallied 22.8% in the last trading session to close at $182.64. This move can be attributable to notable volume with a higher n...